These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1212713)

  • 21. [Vaccination against measles].
    Cocchi P; Corti R
    Pediatr Med Chir; 1984; 6(1):5-11. PubMed ID: 6085156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Measles vaccination].
    Enders G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):273-83. PubMed ID: 4145578
    [No Abstract]   [Full Text] [Related]  

  • 23. Studies on the combined use of killed and live measles vaccines. I. Correlation between antibody titers following injection of killed vaccine and clinical reactions after live vaccine inoculation.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):73-9. PubMed ID: 5837766
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vaccination against measles--adverse effects, cause of reduced protective effect in investigated material].
    Enell H; Simonsson H
    Lakartidningen; 1973 Sep; 70(39):3357-8. PubMed ID: 4788642
    [No Abstract]   [Full Text] [Related]  

  • 25. Low antibody response in infants with measles and children with subclinical measles virus infection.
    Cherian T; Joseph A; John TJ
    J Trop Med Hyg; 1984 Feb; 87(1):27-31. PubMed ID: 6716539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experience with vaccination against measles in Czech regions].
    Adam E; Domoráková E; Kratochvílová M; Burian V; Janotová J; Drevo M; Verhun V; Doubková S; Hartl J
    Cesk Pediatr; 1970 Sep; 25(9):438-40. PubMed ID: 5455607
    [No Abstract]   [Full Text] [Related]  

  • 27. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 28. [Detection of neutralizing antibodies against measles virus in Indians of Xingu, Central Brazil].
    Baruzzj RG; Rodrigues MC; Carvalho RP; de Souza-Dias LC
    Rev Inst Med Trop Sao Paulo; 1971; 13(5):356-62. PubMed ID: 5162259
    [No Abstract]   [Full Text] [Related]  

  • 29. Haemagglutination inhibition antibody levels one year after natural measles infection and vaccination.
    Eghafona NO; Ahmad AA; Ezeokoli CD; Emejuaiwe SO
    Microbios; 1991; 67(274):33-6. PubMed ID: 1758308
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seroconversion after measles vaccination in infants and children.
    Seghal S; Sharma RS; Das A; Sebastian M; Arora RR
    J Commun Dis; 1983 Jun; 15(2):75-9. PubMed ID: 6630988
    [No Abstract]   [Full Text] [Related]  

  • 31. Measles immunity after revaccination: results in children vaccinated before 10 months of age.
    Linnemann CC; Dine MS; Roselle GA; Askey PA
    Pediatrics; 1982 Mar; 69(3):332-5. PubMed ID: 7063289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Study on clinical reactions after inoculation of measles vaccine and transition of antibody values. 3. Clinical figure of natural measles after inoculation of measles raw vaccine and the rise and fall of blood antibody values].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1968 Jan; 72(1):21-6. PubMed ID: 5691554
    [No Abstract]   [Full Text] [Related]  

  • 33. Optimum age for measles immunization in Malaysia.
    Chen ST; Lam SK
    Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):493-9. PubMed ID: 4095612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Fever reaction and the effect on antibody formation of vaccination with commercially available KL measles vaccine, with special reference take-rate of live vaccine and need for additional immunization].
    Santo K; Tatsumi H; Kato K; Hanaya T; Abe S
    Nihon Shonika Gakkai Zasshi; 1969 Apr; 73(4):594-9. PubMed ID: 5817479
    [No Abstract]   [Full Text] [Related]  

  • 35. [The clinical evaluation and immunological response of a new measles vaccine].
    Moretti P; Branciaroli A; Di Battista S; Di Filippo A; Di Pietro M; Calafiore P; Di Battista C
    Minerva Pediatr; 1993 Mar; 45(3):83-6. PubMed ID: 8341231
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of clinical reactions and the fluctuation of antibody levels after measles vaccination. (1) Clinical reactions and serum antibody values after vaccination with raw vaccine only].
    Kubota K
    Nihon Shonika Gakkai Zasshi; 1967 Dec; 71(12):1478-83. PubMed ID: 4175590
    [No Abstract]   [Full Text] [Related]  

  • 37. A comparison of Edmonston-B and Schwarz measles vaccine in Malian children.
    Jean-Joseph P; Sow S; Casey HL; Imperato PJ; Henderson RH; Noble J
    Lancet; 1969 Mar; 1(7596):665-7. PubMed ID: 4179897
    [No Abstract]   [Full Text] [Related]  

  • 38. [Age-dependence of measles immunization failures].
    Giesecke H; Brendel P; Schmidt J; Schlenk B
    Z Gesamte Hyg; 1980; 26(10):764-67. PubMed ID: 7467503
    [No Abstract]   [Full Text] [Related]  

  • 39. [Specific prophylaxis in measles. II. Tests with children of a vaccine prepared with transformed live virus (strain M60-5 Huang)].
    Cajal N; Cepleanu M; Sorodoc Y; Ionescu S; Gartner M; Ianopol L; Boghiţoiu G; Friedman O; Huluţă L; Ionescu D
    Stud Cercet Inframicrobiol; 1966; 17(5):377-87. PubMed ID: 5964006
    [No Abstract]   [Full Text] [Related]  

  • 40. Studies on measles in Thailand. II. Field trials of measles vaccine, with special reference to the K-L method.
    Tsuchinda P; Jayavasu J; Sangkawibha N; Okuno Y; Ueda S
    Biken J; 1967 Sep; 10(3):135-41. PubMed ID: 6081222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.